Success of 14-day triple and quadruple therapy for the control of Helicobacter pylori infections in Kohat district

0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Introduction: Helicobacter pylori is an important medical pathogen present in more than half of the world’s population. Various treatment regimen are in use for the eradication of H. pylori, but due to the emergence of antibiotic resistance, its management is a big issue for clinicians. Methods: In this study all suspected cases that had visited District Headquarters Hospital Kohat were considered for screening of H. pylori infections. Preliminary information about their age, gender, general health conditions, occupation, etc. was taken for consideration. After recording initial signs and symptoms, samples were considered for H. pylori detection using stool antigen test and endoscopy. Fourteen-day proton pump inhibitor base triple and quadruple therapy were administered to each patient. Results: In total (n = 178), there were high numbers of positivity in patients aged below 30 years (82; 46.06%), most of whom belonged to rural areas. Conclusion: This study concludes that there were high numbers of positive patients aged below 30 years, and according to this study MEL (Metronidazole + Esomeprazole + Levofloxacin) is the most effective treatment regimen for the eradication of H. pylori.

Cite

CITATION STYLE

APA

Shah, S. F., Paracha, S. A., Ullah, W., Muhammad, I., Iqbal, S., Gul, A., … Zaman, S. (2022). Success of 14-day triple and quadruple therapy for the control of Helicobacter pylori infections in Kohat district. Drug Target Insights, 16(1), 49–53. https://doi.org/10.33393/dti.2022.2481

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free